Vaxon Biotech
http://vaxon-biotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Vaxon Biotech
Deal Watch: Lilly Sends European Commercial Rights For Two Migraine Drugs To Organon
Plus deals involving Biocytogen, Neurocrine and Ona, Aeterna Zentaris/Ceapro, Teva/Biolojic Design, Pathos AI/Rain Oncology, Inhibitor Therapeutics/Johns Hopkins and more.
Pipeline Watch: Phase III Readouts For ADV7103, Pembrolizumab, Upadacitinib
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Execs On The Move, May 2015
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
People In The News: CEO Changes At NGM, Warp Drive Bio, Vaxon
Both AcelRx and Sagent turn to interim CEOs during company transitions.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice